It has been a transformational six months for Marlowe, which in June 2024 announced the completion of the sale of certain Governance, Risk & Compliance (GRC) software and services assets for an EV of £430m (121% of Marlowe’s pre-announcement market cap), and in September 2024, demerged its Occupational Health division to form a separate PLC under the name Optima Health. These transactions unlocked significant value for shareholders and have left the remaining group focused on its Testing, Inspec ....
